SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-011698
Filing Date
2023-07-05
Accepted
2023-07-05 16:05:19
Documents
13
Period of Report
2023-07-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K akya-20230703x8k.htm   iXBRL 8-K 44701
2 EX-10.1 akya-20230703xex10d1.htm EX-10.1 57779
  Complete submission text file 0001558370-23-011698.txt   239358

Data Files

Seq Description Document Type Size
3 EX-101.SCH akya-20230703.xsd EX-101.SCH 3130
4 EX-101.LAB akya-20230703_lab.xml EX-101.LAB 16577
5 EX-101.PRE akya-20230703_pre.xml EX-101.PRE 10453
7 EXTRACTED XBRL INSTANCE DOCUMENT akya-20230703x8k_htm.xml XML 4992
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

IRS No.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40344 | Film No.: 231068764
SIC: 3826 Laboratory Analytical Instruments